Baseline MRI predictors of successful organ preservation in the Organ Preservation in Rectal Adenocarcinoma (OPRA) trial
British Journal of Surgery · 2024
DOI: 10.1093/bjs/znae246 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Surgery, 2024. Verfasst von Hannah Williams und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Colorectal Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Rectal Neoplasms, Adenocarcinoma, Magnetic Resonance Imaging, Neoadjuvant Therapy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Background
Prospective randomized trials have not yet identified baseline features predictive of organ preservation in locally advanced rectal cancers treated with total neoadjuvant therapy and a selective watch-and-wait strategy.
Methods
This was a secondary analysis of the OPRA trial, which randomized patients with stage II–III rectal adenocarcinoma to receive either induction or consolidation total neoadjuvant therapy. Patients were recommended for total mesorectal excision, or watch and wait based on clinical response at 8 ± 4 weeks after completing treatment. Standardized baseline clinical and radiological variables were collected prospectively. Survival outcomes, including total mesorectal excision-free survival, disease-free survival, and overall survival, were assessed by intention-to-treat analysis. Cox proportional hazards models were used to evaluate associations between baseline variables and survival outcomes.
Results
Of the 324 patients randomized for the OPRA trial, 38 (11.7%) had cT4 tumours, 230 (71.0%) cN-positive disease, 101 (32.5%) mesorectal fascia involvement, and 64 (19.8%) extramural venous invasion. Several baseline features were independently associated with recommendation for total mesorectal excision on multivariable analysis: nodal disease (HR 1.66, 95% c.i. 1.12 to 2.48), extramural venous invasion (HR 1.57, 1.07 to 2.29), mesorectal fascia involvement (HR 1.45, 1.01 to 2.09), and tumour length (HR 1.11, 1.00 to 1.22). Of these, nodal disease (HR 2.02, 1.15 to 3.53) and mesorectal fascia involvement (HR 2.02, 1.26 to 3.26) also predicted worse disease-free survival. Age (HR 1.03, 1.00 to 1.06) was associated with overall survival.
Conclusion
Baseline MRI features, including nodal disease, extramural venous invasion, mesorectal fascia involvement, and tumour length, independently predict the likelihood of organ preservation after completion of total neoadjuvant therapy. Mesorectal fascia involvement and nodal disease are associated with disease-free survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, Colorectal Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Department of Surgery, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
- Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
ORCID-Profile: Hannah Williams, Floris S Verheij, Li-Xuan Qin
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Williams, H., Yuval, J. B., Verheij, F. S., Miranda, J., Lin, S. T., Omer, D. M., Qin, L. X., Gollub, M. J., Kim, T. H., Garcia-Aguilar, J., & OPRA Consortium (2024). Baseline MRI predictors of successful organ preservation in the Organ Preservation in Rectal Adenocarcinoma (OPRA) trial. British Journal of Surgery. https://doi.org/10.1093/bjs/znae246
Vancouver
Williams H, Yuval JB, Verheij FS, Miranda J, Lin ST, Omer DM, et al. Baseline MRI predictors of successful organ preservation in the Organ Preservation in Rectal Adenocarcinoma (OPRA) trial. British Journal of Surgery. 2024. doi:10.1093/bjs/znae246
BibTeX
@article{Williams2024,
author = {Williams, Hannah and Yuval, Jonathan B and Verheij, Floris S and Miranda, Joao and Lin, Sabrina T and Omer, Dana M and Qin, Li-Xuan and Gollub, Marc J and Kim, Tae-Hyung and Garcia-Aguilar, Julio and OPRA Consortium, OPRA Consortium},
title = {Baseline MRI predictors of successful organ preservation in the Organ Preservation in Rectal Adenocarcinoma (OPRA) trial},
journal = {British Journal of Surgery},
year = {2024},
doi = {10.1093/bjs/znae246}
}
EUVIMED